Veracity Network, Inc.
Our revolutionary solution is the only one that allows anyone anywhere to easily and quickly detect drugs that are counterfeited, contaminated, or sub-potent.
- Stage Full Product Ready
- Industry Healthcare Services
- Location Melbourne, FL, USA
- Currency USD
- Founded May 2011
- Employees 6
- Website veracitynetwork.us
Company Summary
Veracity Network provides innovative services for the detection of counterfeit pharmaceuticals. Counterfeit pharmaceuticals kill more than 700,000 people each year and counterfeiters generate $100B in profits. Our services allow any distributor or pharmacy to easily and non-intrusively perform a forensic verification of the drug while inside its packaging. Our service will detect counterfeits, contamination, and sub-potent drugs.
Team
-
Brian MayoFounder and CEO
Mr Mayo is a disruptive innovator with a number of industry firsts including the first data communication switch, Voice-over-IP, and virtual private networking (VPN). Mr. Mayo led the engineering and operations teams at Ardent Communications, which sold to Cisco Systems for over $200M and became the largest division at Cisco. Mr Mayo has the technical background to solve the most difficult challenges and business acumen to create new markets.
-
Dr. William MayoChairman of the Scientific Advisory Board
Dr. William Mayo, professor emeritus at Rutgers, taught material science for over 25 years. Dr. Mayo holds a number of patents in new materials as well as novel material analysis techniques. Dr. Mayo also worked for industry stalwarts such as Bell Laboratories &TRW. Dr. Mayo earned his PhD at Rutgers, and performed undergraduate and graduate studies at Carnegie Mellon University with post-doctorate studies at prestigious Bell Laboratories.
-
Al GapschChief Operations Officer
Mr. Gapsch has over 35 years of professional technical management experience. Prior to Secure Pharma Chain, Mr. Gapsch was owner and managed an independent consulting group, Technical Solutions. Mr. Gapsch served as Vice President of Emerge Interactive from its inception through its initial public offering. Mr Gapsch led diverse applications for the US government, commercial maritime operations, banking industry, and animal diagnostics.
-
Charles DozierChief Scientist
With over 35 years of experience with NASA and the Naval Research Laboratory, Mr. Dozier’s primary experience has been in x-ray diffraction and fluorescence. Mr. Dozier’s research included the use of x-ray technologies in weapons development, plasma physics, radiation hardened microelectronics, dosimetry and other material sciences. Mr. Dozier holds a Bachelor of Science and Master of Science degrees from Wake Forest University.
Advisors
-
Melissa MedlockFinancial ControllerUnconfirmedDr. Charles McDonellDiagnostic RadiologyUnconfirmedJohn HollenbachPharmaceuticalsUnconfirmed
-
Dr. Nikitas KleopoulosIndian River Medical CenterUnconfirmedDr. Mark CroftMaterials Science Professor, RutgersUnconfirmedDr. Yoram KalmanMaterials Science, University of IsraelUnconfirmed
-
John MellottInvestment Banker, Bain GroupUnconfirmedRobert PrindivilleDirector of Trilogy Global AdvisorsUnconfirmedJames AnceyPresident at Rock Maple Services LLCUnconfirmed
Previous Investors
-
Department of Homeland SecurityUnconfirmedUniversity of New Jersey, at RutgersUnconfirmedKimball InternationalUnconfirmed
-
Thomas CookPresident of ITT Grinnell CorporationUnconfirmedJack RogersCEO, EquifaxUnconfirmedJack GruberNorthwestern Mutual Financial NetworkUnconfirmed
-
Paul BeckerBecker Investments, LLCUnconfirmedRobert WashburnWashburn CapitalUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.